Evidence-based opioid stewardship delivered directly within existing EMR workflows. Supports prescribing, monitoring, documentation, and continuity of care.
One platform for safer prescribing, better outcomes, and coordinated care. Designed around the natural workflow of prescribing, monitoring, optimization, and continuity of care, the RxAdvisor Platform brings together clinical intelligence, evidence, and automation in one integrated experience.
Click anywhere on image to enlarge.
Evidence-based opioid stewardship delivered directly within existing EMR workflows. Supports prescribing, monitoring, documentation, and continuity of care.
Predict Powered by cliexa, this optional AI module predicts elevated opioid use disorder risk before clinical deterioration, with explainable contributing factors.
Mayo Clinic Platform Qualified
Balances expected clinical benefit with medication-related risk to support individualized treatment decisions.
Patent Pending: US20210043292A1
Identifies overdose risk and connects patients, families, and communities to naloxone, overdose prevention, and recovery resources.
Patented: US12475984B2
A patented tool that creates individualized tapering and deprescribing plans while monitoring progress and maintaining continuity of care.
Patented: US12475984B2
A patented, closed-loop referral management tool connecting patients with behavioral health, addiction treatment, pain management, and community resources.
Patented: US11640857B2
Rather than addressing isolated clinical events, the RxAdvisor Platform supports longitudinal medication management across the entire prescribing lifecycle.
The result is improved clinical decision making, better patient outcomes, reduced healthcare costs, and stronger support for value-based care.
MONITOR • PREDICT • OPTIMIZE • REDUCE RISK • CONNECT PATIENTS TO CARE